Search News:
By Year :
Latest
|
All
|
2026
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
29 December 2025
Acknowledgment of News Letter from the Office of the Securities and Exchange Commission ("SEC") No. 338/2568
26 November 2025
Notification of the Resignation of Independent Director and Member of Audit Committee and Appoint a new Member of Audit Committee in Place of the Resigned Director
12 November 2025
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
12 November 2025
Financial Performance Quarter 3 (F45) (Reviewed)
12 November 2025
Financial Statement Quarter 3/2025 (Reviewed)
12 November 2025
Extension of the period for utilization of proceeds from the issuance and offering of debentures No.1/2024
30 September 2025
Invitation to Shareholders to Propose Agenda, Director Nominees and any inquiries in advance of the 2026 Annual General Meeting of Shareholders
26 September 2025
New shares of THG to be traded on September 29, 2025
25 September 2025
Increase of Paid-up Capital of Thonburi Healthcare Group Public Company Limited
24 September 2025
Report on the results of sale of common shares offered to all common shares' shareholders (F53-5)
29 August 2025
Disclosure of the notice of allotment of newly issued ordinary shares to existing shareholders in proportion to their shareholdings (Rights Offering) on the Company's website
26 August 2025
New shares of THG to be traded on August 27, 2025
25 August 2025
Increase of Paid-up Capital of Thonburi Healthcare Group Public Company Limited
22 August 2025
Report on the results of sale of common shares offered to private placement (F53-5)
14 August 2025
Determination of subscription &payment date for newly issued shares allocated through PP & RO, determination of record date for shareholders entitled to allotment of newly issued shares to existing shareholders (RO) (Revised No.2)
13 August 2025
Determination of subscription &payment date for newly issued shares allocated through PP & RO, determination of record date for shareholders entitled to allotment of newly issued shares to existing shareholders (RO) (Revised)
13 August 2025
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
13 August 2025
Financial Statement Quarter 2/2025 (Reviewed)
13 August 2025
Financial Performance Quarter 2 (F45) (Reviewed)
04 August 2025
Change of the Authorized Directors (Revised)
<<<
<
/ 3
>
>>>